• Revvity In Vitro Diagnostic Assay, Novel Blood Pressure Monitor, Partnerships, More

    Oct 30 | Diagnostics World | Revvity launches the in vitro diagnostic EURORealTime APOE assay in European countries that accept the CE mark; Withings Health Solutions announces a first-of-its-kind cellular blood pressure monitor; and more. More

  • Follow the Money: Sepsis Diagnostic Test, Next-Gen Tau Tangle Pathology, More

    Oct 29 | Diagnostics World | Cytovale plans to commercially expand IntelliSep, the company’s sepsis diagnostic test, to more hospital emergency departments and health systems nationwide; C2N Diagnostics will continue to develop their next-generation tests specific to tau tangle pathology; and more. More

  • Owkin, AstraZeneca Plan AI Tool for BRCA Screening

    Oct 25 | Diagnostics World | Owkin and AstraZeneca announced a new partnership this month to develop an AI-powered tool to pre-screen for germline BRCA (gBRCA) mutations in breast cancer directly from digitized pathology slides. As part of Owkin’s ongoing collaboration with Gustave Roussy and The Centre Léon Bérard through PortrAIt, a French consortium to accelerate precision medicine through AI-enabled digital pathology, this tool aims to significantly accelerate and expand access to gBRCA testing that too many patients may not be considered for. More

  • New Eye Tracker Could Ease Diagnoses for Neurological Disorders

    Oct 16 | Diagnostics World | Dr. Jae-Hyun Ryou, a mechanical engineer at the University of Houston, has developed a breakthrough wearable eye-tracking system aimed at enhancing brain studies through continuous monitoring. The flexible piezoelectric eye movement sensor array (F-PEMSA) consists of three small sensors, each smaller than a penny, which attach comfortably to the upper, mid, and lower temple. More

  • Breath Sampling Method Could Help Doctors Treat Tricky Respiratory Infections

    Oct 15 | Diagnostics World | As the departments of Defense and Homeland Security are acutely aware, national security and human health have a lot of crossover, including biothreats and infectious diseases. Their investment in instrumentation for rapid analysis of biologic aerosols in the late 1990s is now being creatively repurposed by engineers at Zeteo Tech, together with some novel breath sampling techniques, for the early detection of respiratory infections. More

  • AI Stethoscope Performs in Practice

    Oct 08 | Diagnostics World | Recent studies from researchers at Imperial College London have demonstrated how AI can identify patients with significantly higher risk of experiencing major adverse cardiac events (MACE), including heart attacks and heart failure, and how such a tool can be incorporated into the clinic. More

  • The World Of Precision Medicine Through Digitized Pathology

    Oct 04 | Diagnostics World | It is no surprise that clinical trial sponsors are slowly embracing new tools and technologies to achieve greater levels of precision and efficiency needed in an increasingly demanding and competitive drug discovery and development landscape. Where there was once hesitation due to the unknowns of straying from historical analytic processes, there has been exponential growth in the application of digital pathology within clinical research and development efforts in recent years. More

  • New Pathology Foundation Models, Tutorials for Whole Slide Images

    Oct 03 | Diagnostics World | Proscia yesterday launched Concentriq Embeddings for whole slide images and the Proscia AI Toolkit, a collection of tutorials and functions to help teams rapidly integrate Concentriq Embeddings into their workflows. More

  • Resolving Variants of Uncertain Significance With a Skin Sample

    Oct 01 | Diagnostics World | In a first for genetic diagnostics, a pair of Nobel-Prize-winning technologies are being repurposed for obtaining RNA from disease-causing genes that are expressed in neither blood nor skin. The feat comes from the Neurobiology Research Group at the University of Adelaide’s School of Biomedicine, led by Lachlan Jolly, Ph.D., which aims to resolve the pathogenicity of 300 variants of uncertain significance (VUSs) under a government-funded, Australia-wide study. More

  • Follow the Money: Sepsis Test, Breast Cancer Early Detection, More

    Sep 26 | Diagnostics World | Inflammatix plans to get its lead product, the TriVerity Acute Infection and Sepsis Test (TriVerity), out to market; Syantra aims to commercialize its first test on its patent-pending platform for early detection of breast cancer; and more. More
View more articles

 
DXX-Industry-spotlight

merck


Custom Diagnostic Antibody Development & Manufacturing Services

Overcome Process Challenges by outsourcing your custom antibody production to us. How partnering with an antibody production expert can improve your assay, accelerate launch, and maintain your manufacturing.

Learn more